FIELD: new pharmaceutical formulation in solid form, containing desmopressin as active ingredient and method for production thereof.
SUBSTANCE: claimed composition contains Desmopressin as active ingredient as well as pharmaceutically acceptable excipient, diluent or carrier or mixture thereof, wherein at least one from abovementioned excipient, diluent and carrier represents lactose disaccharide. Said lactose has particle size from 70 to 500 mum.
EFFECT: increased pressing rate without losses of tablet quality.
19 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DESMOPRESSIN PHARMACEUTICAL COMPOSITION AS SOLID DOSED MEDICINAL FORMULATION AND METHOD FOR ITS PREPARING | 2004 |
|
RU2303439C2 |
| COMPOSITION CONTAINING DESMOPRESSIN | 2007 |
|
RU2340351C1 |
| DOSAGE FORM CONTAINING DESLORATADINE AND METHOD FOR PRODUCING IT | 2013 |
|
RU2550958C2 |
| METHOD OF PREPARATION OF HARD MEDICINAL FORM OF DESMOPRESSIN | 2004 |
|
RU2334505C2 |
| DESMOPRESSIN MEDICINAL FORMULATION DISPERSED IN MOUTH CAVITY | 2003 |
|
RU2292903C2 |
| METHOD FOR PREPARING METOPROLOL-CONTAINING MICROPARTICLES | 2002 |
|
RU2292878C2 |
| SOLID MEDICINAL FORM, CONTAINING PROTON PUMP INHIBITOR, AND SUSPENSION OBTAINED FROM IT | 2005 |
|
RU2397756C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2589842C2 |
| SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
